sarcoma (bone and soft tissue cancer) Archive — Page 2 of 2

Side-by-side fluorescence images of tumors in an animal model: the control tumor on the left has fewer visible blood vessels, while the VEGFR1-high osteosarcoma tumor on the right shows denser vascular networks. Red and green fluorescent structures appear against a black background.
September 3, 2014

Aggressive bone cancers build more blood vessels

A subpopulation of bone cancer cells may be responsible for driving clinically aggressive behavior, suggesting new treatment options.

Six adults pose indoors while holding an oversized check dated January 30, 2014, made payable to the Vanderbilt-Ingram Cancer Center for $4,264.37 from the T.J. Martell Foundation; some smaller text is difficult to read.
April 10, 2014

Photo: Sarcoma research support

The FTL Sarcoma Fund, in partnership with the T.J. Martell Foundation, recently presented a gift to the Vanderbilt-Ingram Cancer Center in support of sarcoma research in memory of Warner Music Nashville colleague Lindsay Walleman.

Microscopic histology slide showing pink and purple-stained tissue with densely packed cellular structures and irregular white spaces.
November 21, 2013

Therapeutic target for synovial sarcoma

Inhibitors of a signaling pathway that is critical to synovial sarcoma tumorigenesis may be useful treatments for this aggressive cancer.

Two doctors and three young patients hold a large yellow ribbon and scissors during a clinic opening celebration in a hospital corridor.
April 11, 2013

New clinic links pediatric sarcoma treatment services

J. Carlton Smith noticed severe pain in his knee five years ago during a lacrosse tournament. Smith, then 13 years old, never imagined hearing the diagnosis doctors would give him: osteosarcoma, a cancer of the bone.

Microscopic tissue section stained in pink and purple, showing densely packed abnormal-looking cells surrounding irregular white spaces with numerous red blood cells.
September 27, 2012

Target acquired for aggressive tumor

New therapeutic target for angiosarcoma – an aggressive, highly fatal tumor of the blood vessels – identified.